Biopharma Business

Tag "state program"

Russia’s pharma market to almost double by 2021

The company’s latest report states that key drivers of the Russian healthcare market include improving regulatory guidelines and government initiatives to develop the domestic pharmaceutical industry. The Federal Drug Reimbursement

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements